Puma Biotechnology (PBYI) Goodwill & Intangibles (2017 - 2026)

Puma Biotechnology has reported Goodwill & Intangibles for 10 years, with the latest figure at $39.0 million in Q1 2026.

• For the quarter ending Q1 2026, Goodwill & Intangibles fell 20.0% year-over-year to $39.0 million; the trailing twelve-month figure through Mar 2026 stood at $39.0 million (down 20.0% YoY), and the FY2025 full-year result was $41.4 million, down 19.05% from the prior year.
• Goodwill & Intangibles for Q1 2026 stood at $39.0 million, down from $41.4 million in the prior quarter.
• The five-year high for Goodwill & Intangibles was $70.6 million in Q4 2022, with the low at $39.0 million in Q1 2026.
• Historically, Goodwill & Intangibles has averaged $56.1 million across 5 years, with a median of $58.4 million in 2024.
• Annual changes were most pronounced in 2022 — Goodwill & Intangibles increased 6.78% — and 2026, when it fell 20.0%.
• Puma Biotechnology's Goodwill & Intangibles stood at $70.6 million in 2022, then retreated by 13.79% to $60.9 million in 2023, then fell by 16.0% to $51.1 million in 2024, then dropped by 19.05% to $41.4 million in 2025, then decreased by 5.88% to $39.0 million in 2026.
• The last three Goodwill & Intangibles figures came in at $39.0 million (Q1 2026), $41.4 million (Q4 2025), and $43.8 million (Q3 2025), per Business Quant data.